Atlas Trials

Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

Clinical trial NCT04298853 · COMPLETED

Trial details

NCT number
NCT04298853
Sponsor
Indiana University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Neonatal Abstinence SyndromeNeonatal Opioid WithdrawalNeonatal Opioid Withdrawal Syndrome
Start date
2020-06-30
Primary completion
2021-10-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.